Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer.
van As, Nicholas Griffin, Clare Tree, Alison Patel, Jaymini Ostler, Peter van der Voet, Hans Loblaw, Andrew Chu, William Ford, Daniel Tolan, Shaun
van As, Nicholas
Griffin, Clare
Tree, Alison
Patel, Jaymini
Ostler, Peter
van der Voet, Hans
Loblaw, Andrew
Chu, William
Ford, Daniel
Tolan, Shaun
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2024
Subject
Research Projects
Organizational Units
Journal Issue
Abstract
Whether stereotactic body radiotherapy (SBRT) is noninferior to conventionally or
moderately hypofractionated regimens with respect to biochemical or clinical failure
in patients with localized prostate cancer is unclear.
Citation
N. van As, C. Griffin, A. Tree, J. Patel, P. Ostler, H. van der Voet, A. Loblaw, W. Chu, D. Ford, S. Tolan, S. Jain, P. Camilleri, K. Kancherla, J. Frew, A. Chan, O. Naismith, J. Armstrong, J. Staffurth, A. Martin, I. Dayes, P. Wells, D. Price, E. Williamson, J. Pugh, G. Manning, S. Brown, S. Burnett, and E. Hall
Type
Article
Other
Other